Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166458 | SCV000217254 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000462971 | SCV000562216 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000508250 | SCV000601858 | likely benign | not specified | 2016-12-08 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166458 | SCV000686233 | likely benign | Hereditary cancer-predisposing syndrome | 2016-02-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000508250 | SCV000729329 | likely benign | not specified | 2018-02-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000508250 | SCV000920045 | likely benign | not specified | 2019-08-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000987843 | SCV001137315 | likely benign | Lynch syndrome 4 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000508250 | SCV004243287 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005396489 | SCV006053487 | likely benign | Lynch syndrome 4; Mismatch repair cancer syndrome 4 | 2023-03-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004742296 | SCV005359597 | likely benign | PMS2-related disorder | 2022-03-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |